A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological Conditions
NCT05084417 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2023-11-01
Summary
The primary goal of the study is to collect standardized patient and clinician reported outcome measures for patients diagnosed with a range of dermatological conditions in an academic clinical practice setting. By regularly measuring outcomes longitudinally in patients treated in a real-world setting, this study will provide valuable and necessary information as to the impact of both the disease and its treatments on patients over time and will inform the optimal clinical management of patients with living with dermatological disease.
Conditions
- Atopic Dermatitis
- Dermatology
- Vitiligo
- Alopecia Areata
- Hidradenitis Suppurativa
- Psoriasis
Interventions
- OTHER
-
N/A This is an observational study
As this is an observational study, there are no interventions assigned to either cohort.
Sponsors & Collaborators
-
American Academy of Dermatology
collaborator UNKNOWN -
OM1, Inc.
lead INDUSTRY
Principal Investigators
-
Stefan Weiss, MD · OM1, Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-09
- Primary Completion
- 2026-01-15
- Completion
- 2026-01-15
Countries
- United States
Study Locations
More Related Trials
-
Improved Phototherapy in Patients With Vitiligo
NCT05836441 ·Status: UNKNOWN ·Phase: NA
-
The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo
NCT04942860 ·Status: COMPLETED ·Phase: PHASE3
-
Promoting Repigmentation After Epidermal Cell Suspension Grafting and preVENTing the Loss of Melanocytes Using Topical Ruxolitinib for Vitiligo in Resistant Areas
NCT05872477 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label Safety Study of A-101 Solution
NCT02667288 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Early Systemic Stabilization Therapy on Recent Onset Vitiligo
NCT05037981 ·Status: COMPLETED
-
Study of A-101 for the Treatment of Seborrheic Keratosis
NCT02260180 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Efficacy and the Cutaneous Acceptability of a Dermocosmetic Product in the Repigmentation of Vitiligo
NCT04171427 ·Status: UNKNOWN ·Phase: NA
-
Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo
NCT03123016 ·Status: COMPLETED ·Phase: PHASE2
-
ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis
NCT02126670 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis
NCT01986920 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study
NCT00230373 ·Status: WITHDRAWN ·Phase: PHASE3
-
Efficacy of Autologous Outer-Root-Sheath Melanocytes Transplantation in the Treatment of Vitiligo
NCT01923142 ·Status: TERMINATED ·Phase: PHASE2
-
Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis
NCT05260073 ·Status: COMPLETED
-
Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo
NCT01246921 ·Status: UNKNOWN ·Phase: PHASE4
-
An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses
NCT03487588 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra
NCT03224598 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%
NCT00598832 ·Status: COMPLETED ·Phase: PHASE3
-
Microneedling Combined With Topical Crisaborole 2 % Ointment in Treatment of Vitiligo.
NCT07088276 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of Serum Ceramides C16, C24, and Sphingosine-1-Phosphate (S1P) in Patients With Acne Vulgaris
NCT07250880 ·Status: NOT_YET_RECRUITING
-
Interest of Topical Spironolactone's Administration to Prevent Corticoid-induced Epidermal Atrophy
NCT01407471 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study to Evaluate The Efficacy of Adapalene 0.3% for Use in the Prevention and Treatment of Senile Purpura
NCT01485367 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of Efficacy of Microneedling and Topical Methotrexate Versus Microneedling and Topical 5-flourouracil in Treatment of Vitillgo Patients
NCT05467839 ·Status: COMPLETED ·Phase: NA
-
A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study
NCT00952783 ·Status: COMPLETED
-
Topical Ruxolitinib for the Treatment of Vitiligo
NCT02809976 ·Status: COMPLETED ·Phase: PHASE2
-
Experience With Topical Acne Treatment
NCT05582434 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1